Fiche publication
Date publication
février 2016
Journal
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Auteurs
Membres identifiés du Cancéropôle Est :
Dr CHAIGNEAU Loïc
,
Pr NERICH Virginie
,
Pr PIVOT Xavier
,
Dr MANSI Laura
,
Dr THIERY-VUILLEMIN Antoine
,
Dr DEMARCHI Martin
,
Dr LAKKIS Zaher
Tous les auteurs :
Mansi L, Demarchi M, Bazan F, Delroeux D, Chaigneau L, Thiery-Vuillemin A, Bernhard S, Lakkis Z, Lakkis Z, Nerich V, Pivot X, Kalbacher E
Lien Pubmed
Résumé
The goal of this study was to determine the benefit in terms of time disease control (TDC) achieved by the succession of chemotherapy beyond the third line in patients treated for recurrent epithelial ovarian cancer. Secondary objectives were to identify patients who benefited from treatments beyond 3 lines and to estimate overall survival and disease-free progression lengths.
Mots clés
Adult, Aged, Aged, 80 and over, Antineoplastic Agents, administration & dosage, Female, Humans, Middle Aged, Neoplasms, Glandular and Epithelial, drug therapy, Ovarian Neoplasms, drug therapy, Retrospective Studies
Référence
Int. J. Gynecol. Cancer. 2016 Feb;26(2):261-7
